Skip to main content
Equibles

BARCLAYS PLC

Position in BMY — Bristol Myers Squibb Co

CIK 312069 LONDON, X0
Back to BMY Full portfolio

Position in BMY

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$328,674,902
-$66,072,633 QoQ
Shares Held
5,419,207
-25.9% QoQ
Ownership
0.265%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 99.99464866354062.ToString("F0")% Shared 0.ToString("F0")% None 0.00535133645937496.ToString("F0")%

Common Shares in BMY Over Time

Shares Held

Position Value (USD)

Derivatives in BMY

reported options exposure · as of Mar 31, 2026
CallValue
$8,345,440
CallShares
137,600
PutValue
$31,865,510
PutShares
525,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $8,691,009,698 across 16 Drug Manufacturers - General names. BMY ranks #9 (3.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 JNJ
Johnson & Johnson
 6,786,107 $1,658,795,994
2 LLY
ELI LILLY & Co
 1,563,625 $1,438,175,365
3 ABBV
AbbVie Inc.
 5,571,610 $1,211,769,456
4 AZN
Astrazeneca PLC
 5,491,992 $1,083,130,660
5 MRK
Merck & Co., Inc.
 7,557,518 $909,093,835
6 GILD
Gilead Sciences, Inc.
 5,282,196 $736,179,654
7 AMGN
Amgen Inc
 1,529,613 $538,194,332
8 PFE
Pfizer Inc
 14,689,187 $412,472,368

All Filings in BMY

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $31,865,510 525,400
2026-03-31 $328,674,902 5,419,207
2026-03-31 $8,345,440 137,600
2025-12-31 $125,248,680 2,322,000
2025-12-31 $3,106,944 57,600
2025-12-31 $394,747,535 7,318,271
2025-09-30 $1,682,230 37,300
2025-09-30 $14,075,710 312,100
2025-09-30 $412,082,305 9,137,080
2025-06-30 $96,287,829 2,080,100
2025-06-30 $1,351,668 29,200
2025-06-30 $431,496,399 9,321,590
2025-03-31 $511,114,495 8,380,300
2024-12-31 $262,383,987 4,639,038
2024-12-31 $6,611,864 116,900
2024-12-31 $4,044,040 71,500
2024-09-30 $3,699,410 71,500
2024-09-30 $353,481,986 6,831,890
2024-09-30 $6,146,712 118,800
2024-06-30 $4,580,759 110,300
2024-06-30 $296,363,642 7,136,134
2024-03-31 $330,607,389 6,096,393
2024-03-31 $2,104,124 38,800
2024-03-31 $8,215,845 151,500
2023-12-31 $351,109,658 6,842,909
2023-12-31 $282,205 5,500
2023-09-30 $317,408,511 5,468,789
2023-09-30 $2,321,600 40,000
2023-06-30 $30,350,670 474,600
2023-06-30 $393,775,768 6,157,557
2023-03-31 $281,303,226 4,058,624
2023-03-31 $10,646,016 153,600
2022-12-31 $331,252,472 4,603,926
2022-12-31 $30,578,750 425,000
2022-12-31 $35,154,770 488,600
2022-09-30 $280,449,336 3,944,990
2022-06-30 $294,294,770 3,822,010
2022-03-31 $366,525,079 5,018,829
2021-12-31 $15,144,815 242,900
2021-12-31 $452,937,458 7,264,434
2021-12-31 $3,117,500 50,000
2021-09-30 $414,753,888 7,009,530
2021-09-30 $6,289,771 106,300
2021-06-30 $420,966 6,300
2021-06-30 $311,720,108 4,665,072
2021-03-31 $252,729,462 4,003,318
2021-03-31 $397,719 6,300
2020-12-31 $26,257,299 423,300
2020-12-31 $45,976,636 741,200
2020-12-31 $195,224,846 3,147,265

Report a Problem

Category
Description
Email (optional, for follow-up)